U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
KN-046
Preferred Name English
ERFONRILIMAB
INN  
Official Name English
IMMUNOGLOBULIN G (266-SERINE), BISPECIFIC, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN-CAMELUS BACTRIANUS MONOCLONAL KN046 .GAMMA.-CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GAP) FUSION PROTEIN WITH IMMUNOGLOBULIN G ANTI-(HUMAN CYTOTOXIC T
Common Name English
KN046
Code English
erfonrilimab [INN]
Common Name English
KN 046 [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 759120
Created by admin on Wed Apr 02 06:29:47 GMT 2025 , Edited by admin on Wed Apr 02 06:29:47 GMT 2025
Code System Code Type Description
INN
11617
Created by admin on Wed Apr 02 06:29:47 GMT 2025 , Edited by admin on Wed Apr 02 06:29:47 GMT 2025
PRIMARY INN
FDA UNII
9NP50O6YSA
Created by admin on Wed Apr 02 06:29:47 GMT 2025 , Edited by admin on Wed Apr 02 06:29:47 GMT 2025
PRIMARY
NCI_THESAURUS
C157632
Created by admin on Wed Apr 02 06:29:47 GMT 2025 , Edited by admin on Wed Apr 02 06:29:47 GMT 2025
PRIMARY
SMS_ID
300000038022
Created by admin on Wed Apr 02 06:29:47 GMT 2025 , Edited by admin on Wed Apr 02 06:29:47 GMT 2025
PRIMARY
CAS
2367013-69-0
Created by admin on Wed Apr 02 06:29:47 GMT 2025 , Edited by admin on Wed Apr 02 06:29:47 GMT 2025
PRIMARY
ACTIVE MOIETY
ERFONRILIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966